Actively Recruiting
Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy
Led by National Taipei University of Nursing and Health Sciences · Updated on 2024-11-06
86
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
Sponsors
N
National Taipei University of Nursing and Health Sciences
Lead Sponsor
C
Changhua Christian Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Breast cancer ranks first in Taiwan's top ten gynecological cancers. Chemotherapy is a standard treatment method for colorectal cancer and breast cancer, but while destroying cancer cells, it also destroys healthy cells, resulting in side effects. Peripheral neuropathy can lead to peripheral nerve damage and decreased activity, which affects the patient's quality of life. Currently, there is no standard and effective method for treating peripheral neuropathy caused by chemotherapy. Therefore, the purpose of this study is to investigate the effect of percutaneous electrical acupoint stimulation on improving peripheral nerve symptoms in breast cancer patients undergoing chemotherapy.
CONDITIONS
Official Title
Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with breast cancer for the first time by a physician
- Completed chemotherapy or postoperative adjuvant chemotherapy within 3 months using paclitaxel, vinblastine, or platinum drugs
- Evaluated by a doctor as having chemotherapy-induced peripheral neuropathy with persistent symptoms after chemotherapy
- Peripheral sensory or motor neuropathy grade 2 or higher according to general toxicity criteria (NCI-CTCAE)
- Clear consciousness and able to communicate in Mandarin or Taiwanese
You will not qualify if you...
- Having carcinoma in situ
- Having stage IV cancer
- Having metastatic cancer
- Receiving peripheral neuropathy drugs such as Duloxetine
- Receiving acupoint stimulation therapy
- Allergic to silicone patches
- Having a cardiac pacemaker
- Having diabetic peripheral neuropathy
- Having peripheral neuropathy related to acquired immunodeficiency syndrome
- Receiving treatment for mental illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changhua Christian Hospital
Changhua, Changhua, Taiwan, 500
Actively Recruiting
Research Team
C
CHIA HAO YANG
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here